Latest news
Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $35 - MoomooMoomoo · Sat, 08 Aug 2026 04:10:38 GMTGold Royalty (GROY) Receives a Buy from Maxim Group - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 16:18:00 GMTMaxim Group Maintains Filana Therapeutics(FLNA.US) With Buy Rating, Maintains Target Price $5 - MoomooMoomoo · Thu, 30 Jul 2026 19:31:00 GMT